Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


House Health Reform Bill Increases Drug Rebates, Drops Part D Donut Hole

Executive Summary

The House health care reform bill asks pharmaceutical manufacturers to pay their share of the cost of expanding health care coverage by paying higher rebates on more drugs

You may also be interested in...

House Takes Up PhRMA Offer For Rx Discounts In Donut Hole, But Still Wants More Rebates

House health reform bill includes PhRMA's offer of 50 percent discounts on drugs for Medicare beneficiaries in the Part D donut hole, but also contains Medicaid-level rebates on drugs used by dual-eligibles.

Playing Defense In The House: PhRMA's Donut Hole Deal Garners Support From Democrats

Seventy House Democrats support PhRMA's discount proposal in lieu of phasing out the Part D coverage gap with funds from new rebates collected on drugs for dual-eligibles.

Part D Rebates Can Pay For Filling In Donut Hole, CBO Says

Rebates for Medicare/Medicaid dual eligible enrollees would generate $63 billion over 10 years, Congressional Budget Office estimates; phase-out of donut hole would cost only $47 billion, but most expensive years come after 10 year budget window.

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts